Carol Collins brings 30 years of leadership in the Pharma services industry, across small private and global public companies, serving in CEO, senior executive and non-executive board positions. Her career has involved building entrepreneurial or intrapreneurial businesses, scaling for growth and leading corporate transformation, with both sell-side and buy-side M&A experience.
She spent many years delivering clinical development services for pharma, spanning the continuum from pre-clinical laboratory testing to real-world clinical studies. More recently she has focused on commercialization using digital technologies and monetizing healthcare data.
Carol is located in the UK. She has an MBA from London Business School and a PhD in Biophysics.